LegiList
Congress, Made Clear.
Congress
States
Executive
Lobbying
Analytics
Learn
Briefing
My LegiList
Support
Need all Congresses? Press Enter for expanded federal results.
Federal directories
Bills
Search by number, title, sponsor, chamber or status
Legislators
Member profiles, sponsorships and committee activity
Laws
Follow a public law back to the bill it came from
Committees
House, Senate and joint committee pages
Research
Topics
Policy areas and the bills filed under them
Search Congress
One search across bills, members and laws
The section
Congress
Every federal record in one place
State directories
All states
Dashboards for all fifty
Legislators
Legislator directories, by state
Bills
Bill directories, by state
Categories
Policy categories, by state
Jump straight to one
California
Texas
New York
Florida
Illinois
Ohio
Presidential documents
Presidents
Terms served, and everything each one signed
Orders
Executive orders, in full text
Proclamations
Statements addressed to the country
Bills and the president
Signing statements
What is said on signing a bill into law
Vetoes
Bills refused, and what Congress did next
The section
Executive
Presidential documents at a glance
Who is lobbying
Firms
Registered lobbying firms
Lobbyists
Individual lobbyist records
Clients
The organisations doing the hiring
What is being lobbied
Issues
The subjects filings name
Contributions
Political contributions disclosed on LD-203s
Foreign entities
Foreign interests named in filings
The section
Lobbying
Senate LDA disclosures
Analysis tracks
Activity
Bill volume, action density and conversion into law
Legislators
Sponsorship output and coalition behaviour
Committees
Referral concentration, workload and throughput
Over time
Votes
Close margins, party-line pressure and crossover
Historical trends
Trendlines from the 107th Congress forward
The section
Analytics
Measures across the whole record
LegiList Learn
Browse all explainers
Forty-two guides across seven sections
Glossary
Bills, votes and committees, defined
Start here
How Congress works
Procedural language in plain English, free and without an account
Weekly Briefing
This week's issue
What Congress did in the last seven days
Back issues
Every issue published, as a page and as a PDF
By email
Have it on Sunday
One issue a week, free, unsubscribe any time
Menu
Congress
Bills
Legislators
Laws
Committees
Topics
Search Congress
States
All states
Legislators
Bills
Categories
Executive
Home
Presidents
Orders
Proclamations
Statements
Vetoes
Lobbying
Home
Firms
Lobbyists
Clients
Issues
Contributions
Foreign entities
Analytics
Activity
Legislators
Committees
Votes
Historical trends
Learn
Browse all explainers
Glossary
Briefing
This week's issue
Back issues
My LegiList
Support LegiList
Home
›
Lobbying
›
Filing
Registration
2024
3rd Quarter (July 1 - Sep 30)
Foreign Entity
Firm
SIDLEY AUSTIN LLP
Client
INTERCEPT PHARMACEUTICALS, INC.
Income
—
Expenses
—
Official Senate LDA Document
Lobbying Activities
Health Issues
FDAs regulation of rare disease drugs
Lobbyists
MICHAEL E BORDEN
Senior Counsel, House Financial Services Committee; Counsel, House Financial Services Committee; Le…
PATRICIA LOUISE DELOATCHE
Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assista…
Foreign Entities
ALFASIGMA S.P.A.
Country:
Italy
Ownership:
100.0%